Meiju Ji

4.5k total citations
116 papers, 3.5k citations indexed

About

Meiju Ji is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Meiju Ji has authored 116 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Molecular Biology, 23 papers in Oncology and 23 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Meiju Ji's work include Epigenetics and DNA Methylation (24 papers), Thyroid Cancer Diagnosis and Treatment (22 papers) and RNA modifications and cancer (20 papers). Meiju Ji is often cited by papers focused on Epigenetics and DNA Methylation (24 papers), Thyroid Cancer Diagnosis and Treatment (22 papers) and RNA modifications and cancer (20 papers). Meiju Ji collaborates with scholars based in China, United States and Netherlands. Meiju Ji's co-authors include Peng Hou, Haixia Guan, Mingzhao Xing, Bingyin Shi, Qi Yang, Nongyue He, Yiping Qu, Fang Sui, Demao Yao and Jing Shi and has published in prestigious journals such as Physical Review Letters, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Meiju Ji

110 papers receiving 3.4k citations

Peers

Meiju Ji
Peng Hou China
Efisio Puxeddu Italy
Iris E. Eder Austria
Libero Santarpia Italy
D M Peehl United States
Robert A. Sikes United States
Daniel Gioeli United States
Oliver Stoeltzing United States
Elizabeth Buck United States
Gaosong Wu China
Peng Hou China
Meiju Ji
Citations per year, relative to Meiju Ji Meiju Ji (= 1×) peers Peng Hou

Countries citing papers authored by Meiju Ji

Since Specialization
Citations

This map shows the geographic impact of Meiju Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiju Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiju Ji more than expected).

Fields of papers citing papers by Meiju Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meiju Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiju Ji. The network helps show where Meiju Ji may publish in the future.

Co-authorship network of co-authors of Meiju Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Meiju Ji. A scholar is included among the top collaborators of Meiju Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meiju Ji. Meiju Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Yan, et al.. (2024). USP44 inactivation accelerates the progression of thyroid cancer by inducing ubiquitylation and degradation of p21. International Journal of Biological Sciences. 20(13). 5223–5238. 1 indexed citations
3.
Chen, Quan, et al.. (2024). Engineering PD-L1 targeted liposomal canagliflozin achieves multimodal synergistic cancer therapy. Chemical Engineering Journal. 498. 155074–155074. 5 indexed citations
4.
Sui, Fang, Guanjie Wang, Juan Liu, et al.. (2024). Targeting NG2 relieves the resistance of BRAF-mutant thyroid cancer cells to BRAF inhibitors. Cellular and Molecular Life Sciences. 81(1). 238–238. 2 indexed citations
5.
Wang, Guanjie, Jianying Li, Fang Sui, et al.. (2024). High expression of RTEL1 predicates worse progression in gliomas and promotes tumorigenesis through JNK/ELK1 cascade. BMC Cancer. 24(1). 385–385. 5 indexed citations
6.
Yang, Qi, Hui Dang, Jiaxin Liu, et al.. (2023). Hypoxia switches TET1 from being tumor-suppressive to oncogenic. Oncogene. 42(20). 1634–1648. 13 indexed citations
7.
Li, Xinru, Yan Liu, Juan Liu, et al.. (2023). STAG2 inactivation reprograms glutamine metabolism of BRAF-mutant thyroid cancer cells. Cell Death and Disease. 14(7). 454–454. 4 indexed citations
8.
9.
Chen, Pu, et al.. (2022). Cohesin <b><i>RAD21</i></b> Gene Promoter Methylation Correlated with Better Prognosis in Breast Cancer Patients. Cytogenetic and Genome Research. 162(3). 109–118. 2 indexed citations
10.
Chen, Pu, et al.. (2022). EGFL7 drives the evolution of resistance to EGFR inhibitors in lung cancer by activating NOTCH signaling. Cell Death and Disease. 13(10). 910–910. 11 indexed citations
11.
Qu, Yiping, et al.. (2021). Identification of a germline CSPG4 variation in a family with neurofibromatosis type 1-like phenotype. Cell Death and Disease. 12(8). 765–765. 2 indexed citations
12.
Su, Xi, Chao Feng, Simeng Wang, et al.. (2021). The noncoding RNAs SNORD50A and SNORD50B-mediated TRIM21-GMPS interaction promotes the growth of p53 wild-type breast cancers by degrading p53. Cell Death and Differentiation. 28(8). 2450–2464. 40 indexed citations
13.
Wang, Simeng, Xinrui Zhou, Lihong Chen, et al.. (2021). Atovaquone-HSA nano-drugs enhance the efficacy of PD-1 blockade immunotherapy by alleviating hypoxic tumor microenvironment. Journal of Nanobiotechnology. 19(1). 302–302. 36 indexed citations
14.
15.
Li, Yujun, Qi Yang, Haixia Guan, et al.. (2018). ZNF677 Suppresses Akt Phosphorylation and Tumorigenesis in Thyroid Cancer. Cancer Research. 78(18). 5216–5228. 53 indexed citations
16.
Wang, Na, Wei Jing, Jun Pu, et al.. (2018). TBX1 Functions as a Tumor Suppressor in Thyroid Cancer Through Inhibiting the Activities of the PI3K/AKT and MAPK/ERK Pathways. Thyroid. 29(3). 378–394. 40 indexed citations
17.
Li, Yiqi, Xinru Li, Jun Pu, et al.. (2018). c-Myc Is a Major Determinant for Antitumor Activity of Aurora A Kinase Inhibitor MLN8237 in Thyroid Cancer. Thyroid. 28(12). 1642–1654. 23 indexed citations
18.
Ji, Meiju, et al.. (2015). HIV and smoking: associated risks and prevention strategies. SHILAP Revista de lepidopterología. 7 indexed citations
19.
Zhang, Lihong, Jing Shi, Xu Li, et al.. (2011). Aberrant DNA methylation of drug metabolism and transport genes in nodular goiter. Thyroid Research. 4(1). 15–15. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peng Hou Breakdown of academic impact, for papers by Efisio Puxeddu Breakdown of academic impact, for papers by Iris E. Eder Breakdown of academic impact, for papers by Libero Santarpia Breakdown of academic impact, for papers by D M Peehl Breakdown of academic impact, for papers by Robert A. Sikes Breakdown of academic impact, for papers by Daniel Gioeli Breakdown of academic impact, for papers by Oliver Stoeltzing Breakdown of academic impact, for papers by Elizabeth Buck Breakdown of academic impact, for papers by Gaosong Wu
Rankless by CCL
2026